Advertisement
Mr. Joseph Esposito, Chairman of the Board of Directors, commented,"Richard Wolfe is an outstanding addition to the Aduromed board. His provenleadership, deep understanding of the healthcare public policy and advocacyarena and his ability to develop innovative programs has earned him broadrecognition. We value this forward thinking approach and know that hisexpertise and reputation will augment our board as we develop and execute ourstrategic plan."
Advertisement
Mr. Wolfe added, "It is clear to me that Aduromed has innovative andindustry-leading technology and, I am eager to assist them as they implementtheir growth initiatives. I believe their integrated technology addresses theissues of most concern to healthcare organizations, which are seeking easy toimplement solutions for handling challenges associated with regulated medicalwaste that are cost effective, mitigate risk, and enhance institutions' Greenprofiles and standing in host communities. I am honored to join the Aduromedboard and look forward to helping them deliver value to their shareholders."
About Aduromed Industries, Inc.
Aduromed Industries, Inc. is a provider of innovative technology andservices for the onsite treatment and disposal of regulated medical waste.Aduromed's flagship MedClean(R) Series systems are fully integrated, turnkeytechnology solutions that enable hospitals and other healthcare providers tosafely, efficiently and cost-effectively convert bio-hazardous regulatedmedical waste into sterile, unrecognizable material suitable for disposal asmunicipal solid waste. Aduromed was founded in 1997 with corporateheadquarters, research and development and distribution facilities located inBethel, Connecticut. Further information on Aduromed can be found athttp://www.aduromed.com and in filings with the Securities and ExchangeCommission found at http://www.sec.gov.
Statements about our future expectations are "forward-looking statements"within the meaning of applicable Federal Securities Laws, and are notguarantees of future performance. When used herein, the words "may," "will,""should," "anticipate," "believe," "appear," "intend," "plan," "expect,""estimate," "approximate," and similar expressions are intended to identifysuch forward-looking statements. These statements involve risks anduncertainties inherent in our business, including those set forth in our mostrecent Annual Report on Form 10-K for the year ended December 31, 2007, filedwith the SEC on March 31, 2008, and other filings with the SEC, and aresubject to change at any time. Our actual results could differ materially fromthese forward-looking statements. We undertake no obligation to updatepublicly any forward-looking statement.Contacts: Aduromed Industries, Inc. Investor Contact: Kevin Dunphy Cameron Donahue Chief Financial Officer Hayden IR (203) 798-1080 (651) 653-1854 [email protected] [email protected]
SOURCE Aduromed Industries, Inc.
